Kelly Lawrence W & Associates Inc Pfizer Inc Transaction History

Kelly Lawrence W & Associates Inc

$413 Million
Q4 2024

A detailed history of Kelly Lawrence W & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 9,130 shares of PFE stock, worth $209,259. This represents 0.06% of its overall portfolio holdings.

Number of Shares

9,130

Previous 10,130 9.87%

Holding current value

$209,259

Previous $293,000 17.41%

% of portfolio

0.06%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$24.8 - $30.19 $24,800 - $30,190	-1,000 Reduced 9.87%	9,130 $242,000
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $25,260 - $29,600	1,000 Added 10.95%	10,130 $283,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $189,259 - $245,827	-7,243 Reduced 44.24%	9,130 $262,000
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $30,485 - $35,634	-950 Reduced 5.48%	16,373 $543,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $10,836 - $12,537	-300 Reduced 1.7%	17,323 $635,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $103,529 - $122,753	-2,225 Reduced 11.21%	17,623 $924,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $100,650 - $124,718	-2,200 Reduced 9.98%	19,848 $1.03 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $32,642 - $48,387	790 Added 3.72%	22,048 $1.3 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $504,962 - $569,496	15,078 Added 243.98%	21,258 $770,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $516,442 - $656,700	-15,430 Reduced 71.4%	6,180 $227,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $4,518 - $5,481	-150 Reduced 0.69%	21,610 $707,000
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $29,583 - $33,216	800 Added 3.82%	21,760 $943,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $51,705 - $62,715	1,500 Added 7.71%	20,960 $923,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $40,621 - $47,126	-1,273 Reduced 6.14%	19,460 $691,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $9,978 - $10,587	300 Added 1.47%	20,733 $751,000
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $633,423 - $697,786	20,433	20,433 $729,000

Others Institutions Holding PFE

# of Institutions

3,359

Shares Held

3.56B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $129B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.

Account

Kelly Lawrence W & Associates Inc Pfizer Inc Transaction History